Yuh‐Pyng Sher

2.3k total citations
52 papers, 1.7k citations indexed

About

Yuh‐Pyng Sher is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yuh‐Pyng Sher has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Immunology. Recurrent topics in Yuh‐Pyng Sher's work include Immunotherapy and Immune Responses (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (6 papers). Yuh‐Pyng Sher is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (6 papers). Yuh‐Pyng Sher collaborates with scholars based in Taiwan, United States and China. Yuh‐Pyng Sher's co-authors include Konan Peck, Pan‐Chyr Yang, Cheng‐Wen Wu, Steve R. Roffler, Shih‐Jen Liu, Liang‐Chuan Lai, Yi-Wen Chu, Mien‐Chie Hung, Yukai Huang and Chia-Li Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Yuh‐Pyng Sher

52 papers receiving 1.6k citations

Peers

Countries citing papers authored by Yuh‐Pyng Sher

Since Specialization

Citations

This map shows the geographic impact of Yuh‐Pyng Sher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuh‐Pyng Sher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuh‐Pyng Sher more than expected).

Fields of papers citing papers by Yuh‐Pyng Sher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuh‐Pyng Sher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuh‐Pyng Sher. The network helps show where Yuh‐Pyng Sher may publish in the future.

Co-authorship network of co-authors of Yuh‐Pyng Sher

This figure shows the co-authorship network connecting the top 25 collaborators of Yuh‐Pyng Sher. A scholar is included among the top collaborators of Yuh‐Pyng Sher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuh‐Pyng Sher. Yuh‐Pyng Sher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy 2024 ·Nature Cancer ·Yukai Huang, Wei‐Chung Cheng, (unknown), Juan‐Cheng Yang, Yang‐Chang Wu, Heng‐Hsiung Wu, (unknown), (unknown), (unknown), Chih‐Hao Lu, (unknown), Shih‐Jen Liu, (unknown), Ching‐Chan Lin, Chia‐Ning Shen, Mien‐Chie Hung, Jaw‐Town Lin, Chun‐Chieh Yeh, Yuh‐Pyng Sher	14
2	Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment 2023 ·Molecular Oncology ·(unknown), Chun‐Chieh Yeh, (unknown), (unknown), (unknown), (unknown), Ching‐Chan Lin, Chih‐Hua Chao, (unknown), Ling‐Chu Chang, Lu‐Hai Wang, Yuh‐Pyng Sher	5
3	ADAM9 drives immunosuppressive environment for lung tumor progression 2023 ·The Journal of Immunology ·Yuh‐Pyng Sher, (unknown), Shih‐Jen Liu	1
4	Articulatin B chain induced dendritic cells maturation and driven type I T helper cells and cytotoxic T cells activation 2022 ·Life Sciences ·(unknown), Yuh‐Pyng Sher, Hui‐Chen Chen, Wei‐Chung Cheng, (unknown), Chen‐Chen Lee	5
5	Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma 2021 ·Molecular Therapy — Nucleic Acids ·(unknown), Kai‐Wen Hsu, (unknown), Yu‐Feng Lin, George T.Y. Chen, (unknown), (unknown), Heng‐Hsiung Wu, Chia‐Yang Li, Shu‐Chi Wang, Min-Zu Wu, Yuh‐Pyng Sher, Wei‐Chung Cheng	10
6	Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma 2021 ·Theranostics ·Wei‐Chung Cheng, Chun‐Yu Chang, (unknown), (unknown), (unknown), (unknown), (unknown), Shu‐Fen Chiang, Kevin Chih‐Yang Huang, Liang‐Chuan Lai, Tzu‐Pin Lu, K. S. Clifford Chao, Yuh‐Pyng Sher	31
7	ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma 2021 ·International Journal of Biological Sciences ·(unknown), (unknown), (unknown), Wei‐Chung Cheng, Wei-Chao Chang, Guan-Chin Tseng, (unknown), Yukai Huang, (unknown), Han‐Shui Hsu, Yi-Fan Jiang, Chen-Yuan Lin, Liang‐Chuan Lai, Li X, Yuh‐Pyng Sher	13
8	EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis 2020 ·Redox Biology ·Chi‐Chen Fan, (unknown), Chen‐Yuan Lin, Ling‐Chu Chang, Juan‐Cheng Yang, (unknown), Yuh‐Pyng Sher, Shao‐Chun Wang, Michael Hsiao, Wei‐Chao Chang	42
9	Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression 2020 ·Theranostics ·Ching‐Chan Lin, Yukai Huang, (unknown), (unknown), (unknown), (unknown), (unknown), Wei‐Chung Cheng, Wei‐Chao Chang, Tzu‐Hung Hsiao, Liang‐Chuan Lai, Jin‐Yuan Shih, Yu-Huei Liu, K. S. Clifford Chao, Jennifer L. Hsu, Pei‐Chih Lee, Xian Wen Sun, Mien‐Chie Hung, Yuh‐Pyng Sher	26
10	Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis 2019 ·Scientific Reports ·(unknown), Ching‐Heng Lin, Tzu-Hung Hsiao, (unknown), (unknown), (unknown), Yuh‐Pyng Sher	49
11	Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice 2016 ·Cancer Letters ·(unknown), Ming‐Hsi Huang, Yu‐Wen E. Chang, I‐Hua Chen, Steve R. Roffler, Bing‐Mae Chen, Yuh‐Pyng Sher, Shih‐Jen Liu	12
12	ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis 2015 ·Scientific Reports ·Kuo-Liang Chiu, (unknown), (unknown), (unknown), (unknown), Chen-Yuan Lin, Pei–Yuan Su, Liang‐Chuan Lai, Yuh‐Pyng Sher	29
13	ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway 2014 ·Cancer Research ·Chen-Yuan Lin, Hung‐Jen Chen, (unknown), Liang‐Chuan Lai, Tzu‐Pin Lu, Guan-Chin Tseng, (unknown), (unknown), Jennifer L. Hsu, Shian‐Ying Sung, Mien‐Chie Hung, Yuh‐Pyng Sher	69
14	Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways 2014 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), (unknown), (unknown), Yuh‐Pyng Sher, Wayne Huey‐Herng Sheu, Chia‐Che Chang, Tsung‐Han Lee	40
15	A Novel HLA-A2–restricted CTL Epitope of Tumor-associated Antigen L6 can Inhibit Tumor Growth In Vivo 2012 ·Journal of Immunotherapy ·Shih‐Hsin Tu, (unknown), (unknown), Hsin‐Yu Liu, Yuh‐Pyng Sher, (unknown), Pele Chong, Steve R. Roffler, Guan-Chin Tseng, Hsin–Wei Chen, Shih‐Jen Liu	15
16	Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer 2011 ·Molecular Cancer Therapeutics ·Yuh‐Pyng Sher, Shih‐Jen Liu, (unknown), (unknown), (unknown), Zhenbo Han, Long‐Yuan Li, Jin‐Shing Chen, Cheng‐Wen Wu, Mien‐Chie Hung	13
17	Nuclear ErbB2 Enhances Translation and Cell Growth by Activating Transcription of Ribosomal RNA Genes 2011 ·Cancer Research ·Long‐Yuan Li, (unknown), Yi‐Hsien Hsieh, Ying‐Nai Wang, (unknown), (unknown), Hui‐Yu Chen, Peng‐Ju Chien, (unknown), (unknown), Chien‐Chen Lai, Yuh‐Pyng Sher, Huang‐Chun Lien, Chang‐Hai Tsai, Mien‐Chie Hung	59
18	A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide 2010 ·Molecular Immunology ·(unknown), Hsin–Wei Chen, (unknown), (unknown), Hsin‐Yu Liu, Yuh‐Pyng Sher, (unknown), (unknown), (unknown), Mei‐Yu Chen, Ai-Hsiang Chou, Pele Chong, Shih‐Jen Liu	43
19	Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non–Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness 2006 ·Cancer Research ·Yuh‐Pyng Sher, (unknown), Ruey‐Hwang Chou, (unknown), Wun‐Shaing Wayne Chang, Chun‐Houh Chen, Pan‐Chyr Yang, Cheng‐Wen Wu, Chia-Li Yu, Konan Peck	56
20	Development of High-density DNA Microarray Membrane for Profiling Smoke- and Hydrogen Peroxide-induced Genes in a Human Bronchial Epithelial Cell Line 2001 ·American Journal of Respiratory and Critical Care Medicine ·Ken Y. Yoneda, Konan Peck, (unknown), (unknown), Yuh‐Pyng Sher, Jeremy J.W. Chen, Pan‐Chyr Yang, Yin Chen, Reen Wu	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact